Neurocess
Wearable technology for healthcare, gaming, and professional athletes
Neurocess operates in consumer devices based in Europe, Middle East, and Africa (EMEA), founded in 2018.
Profile
Neurocess’ clinical-level EMG-derived muscle data provides valuable insights related to athletic performance, injury risks, and training efficiency.
Within the consumer devices space, the company focuses on its core offering rather than a broad product line.
The business is associated with Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Seed.
Recorded headcount: 2-10 employees.
Total disclosed funding stands at about $3.4M.
| Sector | Consumer Devices |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Country | Turkey |
| Founded | 2018 |
| Employees | 2-10 |
| Stage | seed |
| Total funding | $3,400,000 |
Website: neurocess.co
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account